Funding opportunity to improve patient care in anti-coagulation
The BMS/Pfizer Alliance is now inviting applications from healthcare organisations for grants to support improvements in patient care in anti-coagulation. This call for grant applications is focused on:
- Stroke prevention in Atrial Fibrillation (AF); and/or
- Management of Venous Thromboembolism (VTE)
The alliance is particularly interested in receiving proposals that:
- Accelerate the implementation of NICE CG180 and/or Quality Standard 93 (QS93) for AF patients to reduce their risk of stroke
- Support identification of patients with atrial fibrillation
- Improve anti-coagulation services and pathways with the aim of improving management of VTE patients
- Provide an educational legacy to support improved management of anti-coagulation beyond the time course of the project
- Include a plan for sustaining and upscaling the activity if successful
- Are innovative and involve effective use of resources
- Focus on the patient and involve them in the design, delivery and evaluation of the project.
NHS organisations may apply for funding up to a maximum value of £20,000 and the application period is open until 20 June 2018. Follow this link for more information and to download the application forms.
Atrial Fibrillation is one of the AHSN Network’s core work programmes so we would like to encourage organisations in the South West to apply. We’d also like to hear about your project proposals.
To learn more about the BMS/Pfizer Alliance and the scope of the IPCA grant programme, please visit www.anticoagulationfoundation.co.uk and if you would like more information about the SW AHSN’s AF programme please contact email@example.com.